DaVita Brings New Clinical Research to ASN Kidney Week 2026, Advancing Evidence for the Next Era of Kidney Care
DaVita will present seven studies at ASN Kidney Week 2026, one of its largest research presences at the conference in recent years, spanning expanded hemodialysis, home dialysis, and patient experience. The research positions DaVita in the emerging middle molecule clearance debate, with two studies suggesting expanded HD can benefit broad patient populations while preserving albumin levels.
Key figures
- Patients served
- 298500
- Studies presented
- 7
- Outpatient centers
- 3266
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.